Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Myeloid Sarcoma or Extramedullary Acute Myeloid Leukemia: Experience in Managing Single-Centre Patients Cohort

Aleksina Shatilova, Irina Budaeva, Yuliya Matvienko, Yuliya Mirolyubova, Darya Ryzhkova, Roman Grozov, Konstantin Bogdanov, Elza Lomaia, Olga Kulemina, Renat Badaev, Nadezhda Shnalieva, Yulia Alexeeva, Vladimir Ivanov, Larisa Girshova

Blood (2024) 144 (Supplement 1): 5987.

https://doi.org/10.1182/blood-2024-211246

Published: 2024

Journal Articles

Long-Term Outcomes in Blastic Phase Chronic Myeloid Leukemia - One Center Experience

Darina Zammoeva, Yulia Alexeeva, Dmitry Motorin, Ekaterina Ovsyannikova, Olga Kulemina, Renat Badaev, Nadezhda Shnalieva, Vladimir Ivanov, Galina Salogub, Aleksina Shatilova, Larisa Girshova, Nadiya Siordiya, Irina Budaeva, Elza Lomaia

Blood (2024) 144 (Supplement 1): 6616.

https://doi.org/10.1182/blood-2024-211328

Published: 2024

Journal Articles

Gilteritinib Versus Salvage Chemotherapy for Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Phase 3, Randomized, Multicenter, Open-Label Trial in Asia

Blood (2021) 138 (Supplement 1): 695.

https://doi.org/10.1182/blood-2021-145436

Published: 2021

Journal Articles

Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)

Mikkael A. Sekeres, Larisa Girshova, Vadim A Doronin, Maria Diez-Campelo, David Valcarcel, Suman Kambhampati, Nora-Athina Viniou, Dariusz Woszczyk, Raquel De Paz Arias, Argiris Symeonidis, Achilles Anagnostopoulos, Eduardo Ciliao Munhoz, Uwe Platzbecker, Valeria Santini, Robert J. Fram, Ying Yuan, Douglas V. Faller, Lionel Ades

Blood (2021) 138 (Supplement 1): 242.

https://doi.org/10.1182/blood-2021-146154

Published: 2021

Journal Articles

BCR-ABL1+ AML De Novo and CBF-Leukemia at Relapse: Game of Clones

Olga Kulemina, MD, Nadia Siordia, MD, Konstantin Bogdanov, PhD, Julia Alexeeva, MD PhD, Larisa Girshova, MD PhD, Elza Lomaia, MD PhD, Andrey Zaritskey, MD PhD

Blood (2019) 134 (Supplement_1): 5138.

https://doi.org/10.1182/blood-2019-129815

Published: 2019

Journal Articles

“FLAG” Regimen Induces Deep, Although Short-Term, Responses in Patients Resistant to Tyrosine Kinases Inhibitors in BP CML.

Ekaterina Romanova, MD, Larisa Girshova, MD, Nadia Siordia, MD, Elena Goriunova, MD, Dmitry Motorin, MD PhD, Elza Lomaia, MD PhD, Marina Konopleva, MD PhD

Blood (2014) 124 (21): 5534.

https://doi.org/10.1182/blood.V124.21.5534.5534

Published: 2014

Journal Articles

Efficacy Of Different Therapeutic Approaches In Blastic Phase Of Chronic Myeloid Leukemia: Single Centre Experience

Elza Lomaia, MD, PhD, Ekaterina Romanova, MD, Larisa Girshova, MD, Yulia Alexeeva, MD, PhD, Eugenia Sbityakova, MD, Elena Goriunova, MD, Vladimir Strugov, MD, Natalia Lazorko, MD, Nadia Siordia, MD, Diana Mescheryakova, MD, Tatiana Silina, MD, Dmitry Motorin, MD, PhD, Andrey Zaritskey, MD, PhD

Blood (2013) 122 (21): 5173.

https://doi.org/10.1182/blood.V122.21.5173.5173

Published: 2013

Journal Articles

High WT1 Expression in 2nd CR of AML Is Predictive for Early Relapse (prospective study)

Larisa Girshova, Ekaterina Romanova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Elena Gorunova, Dmitry Motorin, Andrey Zaritskey

Blood (2012) 120 (21): 4812.

https://doi.org/10.1182/blood.V120.21.4812.4812

Published: 2012

Journal Articles

Normal Blood and Bone Marrow Wt1 Expression Level in Extramedullary Relapse in AML Patient

Larisa Girshova, Ekaterina Romanova, Elena Gorunova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Vladimir Ivanov, Andrey Zaritskey

Blood (2012) 120 (21): 4825.

https://doi.org/10.1182/blood.V120.21.4825.4825

Published: 2012

Journal Articles

Isolated Myeloid Sarcoma Involving the Breast

Larisa Girshova, Ekaterina Romanova, Irina Kholopova, Tatiana Nikulina, Julia Mirolubova, Andrey Zaritskey

Blood (2012) 120 (21): 4345.

https://doi.org/10.1182/blood.V120.21.4345.4345

Published: 2012

Journal Articles

Therapy of Refractory AML with Del(5q) with Low-Dose Lenalidomide

Dmitry Motorin, Elena Goryunova, Ekaterina Romanova, Larisa Girshova, Yulia Alexeeva, Tatiana Nikulina, Andrey Zaritskey

Blood (2011) 118 (21): 4286.

https://doi.org/10.1182/blood.V118.21.4286.4286

Published: 2011

NARROW

Myeloid Sarcoma or Extramedullary Acute Myeloid Leukemia: Experience in Managing Single-Centre Patients Cohort

Long-Term Outcomes in Blastic Phase Chronic Myeloid Leukemia - One Center Experience

Gilteritinib Versus Salvage Chemotherapy for Relapsed/Refractory FLT3 -Mutated Acute Myeloid Leukemia: A Phase 3, Randomized, Multicenter, Open-Label Trial in Asia

Pevonedistat (PEV) + Azacitidine (AZA) Versus AZA Alone As First-Line Treatment for Patients with Higher-Risk Myelodysplastic Syndromes (MDS)/Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) with 20-30% Marrow Blasts: The Randomized Phase 3 PANTHER Trial (NCT03268954)

BCR-ABL1+ AML De Novo and CBF-Leukemia at Relapse: Game of Clones

“FLAG” Regimen Induces Deep, Although Short-Term, Responses in Patients Resistant to Tyrosine Kinases Inhibitors in BP CML.

Efficacy Of Different Therapeutic Approaches In Blastic Phase Of Chronic Myeloid Leukemia: Single Centre Experience

High WT1 Expression in 2nd CR of AML Is Predictive for Early Relapse (prospective study)

Normal Blood and Bone Marrow Wt1 Expression Level in Extramedullary Relapse in AML Patient

Isolated Myeloid Sarcoma Involving the Breast

Therapy of Refractory AML with Del(5q) with Low-Dose Lenalidomide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only